Saskatchewan is launching a program to test the genomes of cancer patients who may face life-threatening side-effects from some chemotherapy drugs.
The test identifies genetic variants on a gene that affects the production of a certain enzyme.
Get breaking National news
For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
Previously these tests were done in the U-S with a two-week turnaround time, but they would only take two to seven days once they can be done at the Royal University Hospital in Saskatoon.
The lab expects to test around one thousand patients a year.
- Two of Canada’s wealthiest families have teamed up to make $18M bid for Hudson’s Bay charter
- If cloned meat enters the food supply, will Canadians know?
- Burnaby apologizes for decades of discrimination against people of Chinese descent
- NDP convention delegates call on their own government to build ferries in B.C.
Comments